RedJay Asset Management Inc. Sells 15,000 Shares of Danaher Corporation (NYSE:DHR)

RedJay Asset Management Inc. lowered its stake in Danaher Corporation (NYSE:DHR - Free Report) by 60.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,000 shares of the conglomerate's stock after selling 15,000 shares during the quarter. RedJay Asset Management Inc.'s holdings in Danaher were worth $2,050,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its holdings in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter worth about $27,000. Rialto Wealth Management LLC purchased a new position in Danaher in the fourth quarter worth about $34,000. Hurley Capital LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $34,000. Finally, Dunhill Financial LLC increased its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Stock Down 1.6%

Shares of DHR opened at $198.20 on Monday. The business's 50 day moving average is $194.84 and its 200 day moving average is $208.15. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a market capitalization of $141.84 billion, a PE ratio of 38.48, a price-to-earnings-growth ratio of 2.79 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The firm had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's payout ratio is currently 24.85%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research reports. Robert W. Baird dropped their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Argus decreased their price target on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Jefferies Financial Group reduced their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research note on Tuesday, April 22nd. Finally, Leerink Partners raised their target price on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $248.61.

Insider Buying and Selling at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.20% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.